Major histocompatibility complex associations of ankylosing spondylitis are complex and involve further epistasis with ERAP1

Nature Communications

Volumn 6, Issue , 2015, Pages

  Cortes, Adrian ^a   Pulit, Sara L ^b   Leo, Paul J ^a   Pointon, Jenny J ^c   Robinson, Philip C ^a   Weisman, Michael H ^d   Ward, Michael ^e   Gensler, Lianne S ^f   Zhou, Xiaodong ^g   Garchon, Henri Jean ^h   Chiocchia, Gilles ^h   Nossent, Johannes ^i,j   Lie, Benedicte A ^k   Førre, Øystein ^k   Tuomilehto, Jaakko ^l,m,n   Laiho, Kari ^o   Bradbury, Linda A ^a   Elewaut, Dirk ^p,q   Burgos Vargas, Ruben ^r   Stebbings, Simon ^s   Appleton, Louise ^c   Farrah, Claire ^c   Lau, Jonathan ^c   Haroon, Nigil ^t   Mulero, Juan ^u   Blanco, Francisco J ^v   Gonzalez Gay, Miguel A ^w   Lopez Larrea, C ^x,y   Bowness, Paul ^c   Gaffney, Karl ^z   Gaston, Hill ^aa   Gladman, Dafna D ^t,ab,ac   Rahman, Proton ^ad   Maksymowych, Walter P ^ae   Crusius, J Bart A ^af   Van Der Horst Bruinsma, Irene E ^af   Valle Oñate, Raphael ^ag   Romero Sánchez, Consuelo ^ag   Hansen, Inger Myrnes ^v   Pimentel Santos, Fernando M ^ah   Inman, Robert D ^t   Martin, Javier ^ai   Breban, Maxime ^h   Wordsworth, Bryan Paul ^c   Reveille, John D ^g   Evans, David M ^a,aj   De Bakker, Paul I W ^b   Brown, Matthew A ^a   more..

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NUFFIELD ORTHOPAEDIC CENTRE   (United Kingdom)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF TEXAS   (United States)

^h LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

ⁱ UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^j SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^k OSLO UNIVERSITY HOSPITAL   (Norway)

^l NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^m DANUBE UNIVERSITY KREMS   (Austria)

ⁿ KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^o PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^p GHENT UNIVERSITY HOSPITAL   (Belgium)

^q GHENT UNIVERSITY   (Belgium)

^r UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^s UNIVERSITY OF OTAGO   (New Zealand)

^t UNIVERSITY OF TORONTO   (Canada)

^u HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^v Department of Medicine Dunedin School of Medicine University of Otago ^*  (Norway)

^w Department of Rheumatology Hospital Marques de Valcecillas IFIMAV   (Spain)

^x HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^y Section of Nephrology   (Spain)

^z NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^aa UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ab UNIVERSITY HEALTH NETWORK   (Canada)

^ac UNIVERSITY HEALTH NETWORK   (Canada)

^ad MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^ae UNIVERSITY OF ALBERTA   (Canada)

^af VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^ag UNIVERSIDAD DE LA SABANA   (Colombia)

^ah NOVA MEDICAL SCHOOL   (Portugal)

^ai INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^aj UNIVERSITY OF BRISTOL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMINOPEPTIDASE; ERAP1 PROTEIN, HUMAN; HLA B27 ANTIGEN; HLA B40 ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN;

EPISTASIS; PROTEIN;

ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; EPISTASIS; ERAP1 GENE; EUROPEAN; GENE; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HLA A GENE; HLA B 27 GENE; HLA B GENE; HLA DPB1 GENE; HLA DRB1 GENE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; CLINICAL TRIAL; GENETIC PREDISPOSITION; GENETICS; MULTICENTER STUDY; SPONDYLITIS, ANKYLOSING;

AMINOPEPTIDASES; CASE-CONTROL STUDIES; EPISTASIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HLA-B40 ANTIGEN; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MINOR HISTOCOMPATIBILITY ANTIGENS; POLYMORPHISM, SINGLE NUCLEOTIDE; SPONDYLITIS, ANKYLOSING;

EID: 84930216606     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8146     Document Type: Article

References (47)

1. Brown, M. A. et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum. 40, 1823-1828 (1997).
2. Brewerton, D. A. et al. Ankylosing spondylitis and HL-A 27. Lancet 1, 904-907 (1973).
3. Caffrey, M. F. & James, D. C. Human lymphocyte antigen association in ankylosing spondylitis. Nature 242, 121 (1973).
4. Schlosstein, L., Terasaki, P. I., Bluestone, R. & Pearson, C. M. High association of an HL-A antigen, W27, with ankylosing spondylitis. N. Engl. J. Med. 288, 704-706 (1973).
5. Burton, P. R. et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat. Genet. 39, 1329-1337 (2007).
6. Reveille, J. D. et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat. Genet. 42, 123-127 (2010).
7. Evans, D. M. et al. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat. Genet. 43, 761-767 (2011).
8. International Genetics of Ankylosing Spondylitis Consortium (IGAS) et al. Identification of multiple risk variants for ankylosing spondylitis through highdensity genotyping of immune-related loci. Nat. Genet. 45, 730-738 (2013).
9. Benjamin, R. & Parham, P. HLA-B27 and disease: a consequence of inadvertent antigen presentation? Rheum. Dis. Clin. North Am. 18, 11-21 (1992).
10. Kenna, T. J. & Brown, M. A. Immunopathogenesis of ankylosing spondylitis. Int. J. Clin. Rheumatol. 8, 265-274 (2013).
11. Sherlock, J. P., Buckley, C. D. & Cua, D. J. The critical role of interleukin-23 in spondyloarthropathy. Mol. Immunol. 57, 38-43 (2014).
12. Chang, S. C., Momburg, F., Bhutani, N. & Goldberg, A. L. The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a 'molecular ruler' mechanism. Proc. Natl Acad. Sci. USA 102, 17107-17112 (2005).
13. Saveanu, L. et al. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat. Immunol. 6, 689-697 (2005).
14. Allen, R. L., O'Callaghan, C. A., McMichael, A. J. & Bowness, P. Cutting edge: HLA-B27 can form a novel beta 2-microglobulin-free heavy chain homodimer structure. J. Immunol. 162, 5045-5048 (1999).
15. Chan, A. T., Kollnberger, S. D., Wedderburn, L. R. & Bowness, P. Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis. Arthritis Rheum. 52, 3586-3595 (2005).
16. Diaz-Pena, R. et al. Influence of HLA-B∗5703 and HLA-B∗1403 on susceptibility to spondyloarthropathies in the Zambian population. J. Rheumatol. 35, 2236-2240 (2008).
17. Lopez-Larrea, C. et al. Association of ankylosing spondylitis with HLA-B∗1403 in a West African population. Arthritis Rheum. 46, 2968-2971 (2002).
18. D'Amato, M. et al. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur. J. Immunol. 25, 3199-3201 (1995).
19. Nasution, A. R. et al. HLA-B27 subtypes positively and negatively associated with spondyloarthropathy. J. Rheumatol. 24, 1111-1114 (1997).
20. Turner, M. J. et al. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. J. Immunol. 175, 2438-2448 (2005).
21. DeLay, M. L. et al. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum. 60, 2633-2643 (2009).
22. Campbell, E. C., Fettke, F., Bhat, S., Morley, K. D. & Powis, S. J. Expression of MHC class I dimers and ERAP1 in an ankylosing spondylitis patient cohort. Immunology 133, 379-385 (2011).
23. Ciccia, F. et al. Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. Ann. Rheum. Dis. 73, 1566-1574 (2014).
24. Kenna, T. J. et al. Disease-associated polymorphisms in ERAP1 do not alter endoplasmic reticulum stress in patients with ankylosing spondylitis. Genes Immun. 16, 35-42 (2015).
25. Robinson, W. P. et al. HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum. 32, 1135-1141 (1989).
26. Brown, M. A. et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann. Rheum. Dis. 55, 268-270 (1996).
27. Wei, J. C., Tsai, W. C., Lin, H. S., Tsai, C. Y. & Chou, C. T. HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients. Rheumatology (Oxford) 43, 839-842 (2004).
28. Jia, X. et al. Imputing amino Acid polymorphisms in human leukocyte antigens. PLoS One 8, e64683 (2013).
29. Madden, D. R., Gorga, J. C., Strominger, J. L. & Wiley, D. C. The threedimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70, 1035-1048 (1992).
30. van Gaalen, F. A. et al. Epistasis between two HLA antigens defines a subset of individuals at a very high risk for ankylosing spondylitis. Ann. Rheum. Dis. 72, 974-978 (2012).
31. Takano, M., Miyajima, T., Kiuchi, M., Ohmori, K. & Amemiya, H. Behcet disease and the HLA system. Tissue Antigens 8, 95-99 (1976).
32. Ait Badi, M. A. et al. [Skeletal manifestations in Behcet's disease. A report of 79 cases]. Rev. Med. Interne 29, 277-282 (2008).
33. Taurog, J. D. & Hammer, R. E. Experimental spondyloarthropathy in HLA-B27 transgenic rats. Clin. Rheumatol. 15(Suppl 1): 22-27 (1996).
34. Akram, A. & Inman, R. D. Co-expression of HLA-B7 and HLA-B27 alleles is associated with B7-restricted immunodominant responses following influenza infection. Eur. J. Immunol. 43, 3254-3267 (2013).
35. Akram, A., Lin, A., Gracey, E., Streutker, C. J. & Inman, R. D. HLA-B27, but not HLA-B7, immunodominance to influenza is ERAP dependent. J. Immunol. 192, 5520-5528 (2014).
36. Sawcer, S. et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214-219 (2011).
37. Strange, A. et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat. Genet. 42, 985-990 (2010).
38. Kirino, Y. et al. Genome-wide association analysis identifies new susceptibility loci for Behcet's disease and epistasis between HLA-B∗51 and ERAP1. Nat. Genet. 45, 202-207 (2013).
39. Saper, M. A., Bjorkman, P. J. & Wiley, D. C. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J. Mol. Biol. 219, 277-319 (1991).
40. Blanco-Gelaz, M. A. et al. The amino acid at position 97 is involved in folding and surface expression of HLA-B27. Int. Immunol. 18, 211-220 (2006).
41. Smith, R. A., Myers, N. B., Robinson, M., Hansen, T. H. & Lee, D. R. Polymorphism at position 97 in MHC class I molecules affects peptide specificity, cell surface stability, and affinity for beta2-microglobulin. J. Immunol. 169, 3105-3111 (2002).
42. Kumar, P. et al. Structural basis for T cell alloreactivity among three HLA-B14 and HLA-B27 antigens. J. Biol. Chem. 284, 29784-29797 (2009).
43. Pereyra, F. et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330, 1551-1557 (2010).
44. van der Linden, S., Valkenburg, H. A. & Cats, A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 27, 361-368 (1984).
45. Cortes, A. & Brown, M. A. Promise and pitfalls of the Immunochip. Arthritis Res. Ther. 13, 101 (2011).
46. McLaren, P. J. et al. Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans. Hum. Mol. Genet. 21, 4334-4347 (2012).
47. Raychaudhuri, S. et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat. Genet. 44, 291-296 (2012).